Clearmind Medicine Inc. sets 1-for-10 reverse split for Thursday, May 21, 2026

Listing RiskvolatileImpact60

CMND Price

Stored market data

$1.64-$0.02 (-1.40%)

Previous close $1.66Latest volume 352

Why It Matters

The split changes tradability and liquidity dynamics, can increase price volatility, and often signals delisting avoidance—holders should monitor trading and fractional-share handling.

Summary

Add Stock Radar as a preferred source on GoogleAdd Stock Radar on Google

Clearmind will implement a one-for-ten reverse stock split effective May 21, 2026. Current holders will own one post-split share for every ten pre-split shares, keeping proportional ownership unchanged while per-share price rises and share count falls.

Score60

Score Rationale

volatile

Reverse split materially affects tradability, liquidity, and delisting risk in near term.

Bullish

Higher post-split share price may help meet minimum bid-price listing standards.
Avoiding delisting preserves continued market access and institutional eligibility.
Larger nominal share price can attract some new buyers or ETFs with price filters.

Bearish

Reverse split often signals prior sustained low price or financial stress.
Per-share liquidity will be lower, potentially widening spreads and slippage.
Small shareholders may face fractional-share cash-out or odd-lot processing.
Possible short-term selling pressure and elevated volatility after effectiveness.

Key Evidence

Company will effect a one-for-ten reverse split effective May 21, 2026 (Nasdaq alert).

What To Watch Next

Confirm treatment of fractional shares or cash-out procedures.
Monitor post-split price, spreads, and traded volume changes.
Check SEC filings or company release for rationale and compliance status.
Watch for any market-maker or exchange notices about trading adjustments.

AdvertisementResponsive display

Biotechnology Market Context

SectorHealthcare+0.70%

IndustryBiotechnology-1.26%